AOD-9604
Modified hGH fragment (176-191) studied for fat metabolism and lipolysis research. Interacts with beta-3 adrenergic receptors without growth-promoting effects.
€89.99
10mg
What is AOD-9604?
AOD-9604 is a modified fragment (amino acids 176-191) of human growth hormone. It is studied for its potential role in fat metabolism and lipolysis without the growth-promoting effects of full-length hGH. Research focuses on its interaction with the beta-3 adrenergic receptor pathway.
Why It Matters
Scientists took the fat-burning part of growth hormone and removed everything else. The result: a peptide that targets fat cells specifically, without affecting blood sugar, muscle growth, or other hormones. Went through clinical trials in Australia.
Key Research Areas
- Fat metabolism - stimulates lipolysis and inhibits lipogenesis via the beta-3 adrenergic receptor pathway
- No growth effects - retains fat-burning properties of hGH without influencing IGF-1, blood sugar, or tissue growth
- Cartilage repair - studied for potential regenerative effects on cartilage and connective tissue
- Safety profile - completed Phase 2b clinical trials in Australia with favorable safety data
Specifications
- Purity: ≥98% (HPLC & mass spectrometry verified)
- Form: Lyophilized powder
- Storage: 2–8°C after reconstitution, use within 4 weeks
- CoA: Included with every batch
Related: Retatrutide | MOTS-c
For Research Purposes Only.
